Literature DB >> 19616601

Transmission and expansion of HOXB4-induced leukemia in two immunosuppressed dogs: implications for a new canine leukemia model.

Monica S Thakar1, Xiao-Bing Zhang, Brian C Beard, George E Sale, Erlinda B Santos, Laura Peterson, Hans-Peter Kiem, Brenda M Sandmaier.   

Abstract

OBJECTIVE: There are currently no large animal models to study the biology of leukemia and development of novel antileukemia therapies. We have previously shown that dogs transplanted with homeobox B4 (HOXB4)-transduced autologous CD34(+) cells developed myeloid leukemia associated with HOXB4 overexpression. Here we describe the transmission, engraftment, and expansion of these canine leukemia cells into two genetically unrelated, immunosuppressed dogs.
MATERIALS AND METHODS: Two dogs immunosuppressed after major histocompatibility complex-haploidentical hematopoietic cell transplantation and exhibiting mixed donor-host chimerism were accidentally infused trace amounts of HOXB4-overexpressing leukemia cells from a third-party dog.
RESULTS: Six weeks after infusion of HOXB4-overexpressing leukemia cells, these two dogs rapidly developed myeloid leukemia consisting of marrow and organ infiltration, circulating blasts, and, in one dog, chloromatous masses. Despite neither of these dogs sharing any dog leukocyte antigen haplotypes with the sentinel case, the HOXB4-transduced clones engrafted and proliferated without difficulty in the presence of immunosuppression. Chimerism studies in both dogs confirmed that donor and, in one case, host hematopoietic cell engraftment was lost and replaced by third-party HOXB4 cells.
CONCLUSIONS: The engraftment and expansion of these leukemia cells in dogs will allow studies into the biology of leukemia and development and evaluation of novel antileukemia therapies in a clinically relevant large animal model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19616601      PMCID: PMC2748853          DOI: 10.1016/j.exphem.2009.07.004

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  26 in total

1.  Biochemical characterization of a unique canine myeloid antigen.

Authors:  B M Sandmaier; F G Schuening; J A Bianco; S J Rosenman; I Bernstein; S Goehle; R Storb; F R Appelbaum
Journal:  Leukemia       Date:  1991-02       Impact factor: 11.528

2.  Cytotoxic typing antisera for marrow grafting in littermate dogs.

Authors:  R B Epstein; R Storb; H Ragde; E D Thomas
Journal:  Transplantation       Date:  1968-01       Impact factor: 4.939

3.  Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model.

Authors:  Brenda M Sandmaier; Takahiro Fukuda; Theodore Gooley; Cong Yu; Erlinda B Santos; Rainer Storb
Journal:  Exp Hematol       Date:  2003-02       Impact factor: 3.084

4.  G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required.

Authors:  J M Zaucha; E Zellmer; G Georges; M T Little; R Storb; B Storer; B Torok-Storb
Journal:  Biol Blood Marrow Transplant       Date:  2001       Impact factor: 5.742

5.  High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vector.

Authors:  Xiao-Bing Zhang; Brian C Beard; Grant D Trobridge; Brent L Wood; George E Sale; Reeteka Sud; R Keith Humphries; Hans-Peter Kiem
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 6.  Canine X-linked muscular dystrophy as an animal model of Duchenne muscular dystrophy: a review.

Authors:  B A Valentine; N J Winand; D Pradhan; N S Moise; A de Lahunta; J N Kornegay; B J Cooper
Journal:  Am J Med Genet       Date:  1992-02-01

7.  The canine major histocompatibility complex. Population study of DLA-D alleles using a panel of homozygous typing cells.

Authors:  R F Raff; H J Deeg; V T Farewell; S DeRose; R Storb
Journal:  Tissue Antigens       Date:  1983-05

8.  Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation.

Authors:  Adolfo A Ferrando; Scott A Armstrong; Donna S Neuberg; Stephen E Sallan; Lewis B Silverman; Stanley J Korsmeyer; A Thomas Look
Journal:  Blood       Date:  2003-03-13       Impact factor: 22.113

9.  Cyclosporin A and methotrexate in canine marrow transplantation: engraftment, graft-versus-host disease, and induction of intolerance.

Authors:  H J Deeg; R Storb; P L Weiden; R F Raff; G E Sale; K Atkinson; T C Graham; E D Thomas
Journal:  Transplantation       Date:  1982-07       Impact factor: 4.939

10.  Canine hemophilia B resulting from a point mutation with unusual consequences.

Authors:  J P Evans; K M Brinkhous; G D Brayer; H M Reisner; K A High
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

View more
  5 in total

1.  Evaluation of posttransplant methotrexate to facilitate engraftment in the canine major histocompatibility complex-haploidentical nonmyeloablative transplant model.

Authors:  Monica S Thakar; Erlinda B Santos; Theodore A Gooley; George Sale; Rainer Storb; Hans-Peter Kiem; Brenda M Sandmaier
Journal:  Transplantation       Date:  2010-07-15       Impact factor: 4.939

2.  Insights into leukemia-initiating cell frequency and self-renewal from a novel canine model of leukemia.

Authors:  Suzan Imren; Xiao-Bing Zhang; R Keith Humphries; Hans-Peter Kiem
Journal:  Exp Hematol       Date:  2010-10-08       Impact factor: 3.084

3.  Animal Models for Preclinical Development of Allogeneic Hematopoietic Cell Transplantation.

Authors:  Scott S Graves; Maura H Parker; Rainer Storb
Journal:  ILAR J       Date:  2018-12-31

4.  Future perspectives: therapeutic targeting of notch signalling may become a strategy in patients receiving stem cell transplantation for hematologic malignancies.

Authors:  Elisabeth Ersvaer; Kimberley J Hatfield; Håkon Reikvam; Oystein Bruserud
Journal:  Bone Marrow Res       Date:  2010-10-04

Review 5.  Developments and translational relevance for the canine haematopoietic cell transplantation preclinical model.

Authors:  Scott S Graves; Rainer Storb
Journal:  Vet Comp Oncol       Date:  2020-05-26       Impact factor: 2.385

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.